Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on receiving government subsidies
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the acquisition of European CEP certification for atorvastatin calcium raw materials
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on not revising the “Mino Bonds” conversion price downward
Announcement of Resolutions of the Sixth Meeting of the Fifth Board of Directors of Ningbo Menova Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 6th Meeting of the Fifth Board of Supervisors of Ningbo Menova Pharmaceutical Co., Ltd.
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on holding the 2024 semi-annual results briefing
Ningbo Menova Pharmaceutical Co., Ltd. Investor Relations Activity Record Form (20240902)
Ningbo Menova Pharmaceutical Co., Ltd. 2024 Semi-Annual Report
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on increasing capital to its wholly-owned subsidiary Ningbo Menohua Tiankang Pharmaceutical Co., Ltd.
Special report on the storage and actual use of funds raised in the 2024 semi-annual period of Ningbo Menohua Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Fifth Meeting of the Fifth Board of Supervisors of Ningbo Menova Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Fifth Meeting of the Fifth Board of Directors of Ningbo Menova Pharmaceutical Co., Ltd.
Special report on the storage and actual use of funds raised in the 2024 semi-annual period of Ningbo Menohua Pharmaceutical Co., Ltd.
Summary of the 2024 semi-annual report of Ningbo Menova Pharmaceutical Co., Ltd.
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a duloxetine hydrochloride enteric capsule drug registration certificate
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the holding subsidiary arginine perindopril API passing the CDE technical review
Announcement of Ningbo Menovo Pharmaceutical Co., Ltd. regarding the receipt of government subsidies.
Announcement on the cancellation of the special account for the first issue of Ningbo Menovo Pharmaceutical Co., Ltd.'s raised funds.
Legal Opinion of Guangfa Law Firm, Shanghai Regarding the First Extraordinary General Meeting of Shareholders of Ningbo Menovo Pharmaceutical Co., Ltd. in 2024.
Announcement of resolutions of the first extraordinary general meeting of shareholders of Ningbo Menovo Pharmaceutical Co., Ltd. in 2024.
No Data
No Data